Design of Antigen-Specific Antibody CDRH3 Sequences Using AI and Germline-Based Templates
Toma M. MarinoviD, Alexandra A. Abu-ShmaisiD, Alexis K. JankeiD, Ivelin S. GeorgieviD
Abstract
Antibody-antigen specificity is engendered and refined through a number of complex B cell processes, including germline gene recombination and somatic hypermutation. Here, we present an AI-based technology for de novo generation of antigen-specific antibody CDRH3 sequences using germline-based templates, and validate this technology through the generation of antibodies against SARS-CoV-2. AI-based processes that mimic the outcome, but bypass the complexity of natural antibody generation, can be efficient and effective alternatives to traditional experimental approaches for antibody discovery.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 2
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- De novo generation of antibody CDRH3 with a pre-trained generative large language model
Haohuai He, Bing He, … Jianhua Yao·bioRxiv·Oct 17, 2023
- Generation of antigen-specific paired chain antibody sequences using large language models
Perry T. Wasdin, Nicole V. Johnson, … Ivelin S. Georgiev·bioRxiv·Dec 20, 2024
- Unlocking de novo antibody design with generative artificial intelligence
Amir Shanehsazzadeh, Matt McPartlon, … Sharrol T. Bachas·bioRxiv·Jan 8, 2023
- AI-based antibody discovery platform identifies novel, diverse and pharmacologically active therapeutic antibodies against multiple SARS-CoV-2 strains
C. Moldovan Loomis, T. Lahlali, … R. H. Clark·bioRxiv·Aug 21, 2023
- Novel antibody language model accelerates IgG screening and design for broad-spectrum antiviral therapy
Hannah Faisal Almubarak, Wuwei Tan, … Yang Shen·iSciencePeer-reviewed·Sep 17, 2025
- A high-throughput, automated, cell-free expression and screening platform for antibody discovery
Andrew C. Hunt, Bastian Vögeli, … Michael C. Jewett·bioRxiv·Nov 4, 2021